Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemotoxic snake venom toxins are a heterogeneous group of proteins and peptides found in the venoms of many viperid, some elapid, and colubrid snakes[1][2][3]. The main families include snake venom metalloproteinases (SVMPs) and serine proteases (SVSPs), but also disintegrins, C-type lectin-like proteins, and others. These toxins act principally by disrupting hemostasis: they can break down blood vessel structural proteins, impair blood clotting (either causing excessive clotting followed by consumption of clotting factors, or direct bleeding and coagulopathy), promote tissue damage, inhibit platelet function, and cause vascular leakage, leading to hemorrhage, hypovolemia, organ infarction, and shock[1][3][2]. While some components are structurally and mechanistically related (such as SVMPs being part of a conserved metalloproteinase family), "hemotoxic snake venom toxins" is not a single molecular entity or even a single family, but rather a descriptive group for the pathophysiological effects they induce. These effects are the main cause of morbidity and mortality after bites by viperid snakes and some others. Medical interventions are based on polyclonal antivenoms, which neutralize the toxins by antibody binding, but specific molecular inhibitors are still mostly experimental[1][3].
Antivenoms bind and neutralize toxins, promoting clearance and preventing interaction with blood proteins, endothelium, or other molecular targets. Protease inhibitors inhibit SVMP or SVSP catalytic activity. Chelators bind essential zinc (SVMP) or calcium, blocking enzymatic function.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemotoxic snake venom toxin.